Interest-Driven Attention
On trying to understand my ADHD without medication
I’ve been trying to understand my ADHD without medication lately. Not manage it. Not fix it. Just understand what it actually is when there’s nothing smoothing it out.
For a long time, Adderall gave my days a kind of clean edge. I could begin things. I could continue them. I could finish them, which felt less like an achievement and more like access to a version of myself that functioned in straight lines. It made me compatible with systems that expect consistency.
Pharmacologically, it makes sense. Stimulants like Adderall increase dopamine and norepinephrine availability in the prefrontal cortex, the part of the brain responsible for executive function—planning, working memory, task persistence. It raises the baseline signal. It makes more things feel actionable.
Without it, my attention hasn’t disappeared. It just doesn’t land.
There’s a particular kind of day I keep having. Nothing is wrong. Nothing is especially urgent. There are things I could do, should do, even want to do in a distant, theoretical way. But I don’t begin. Or I begin five things and finish none of them. I move between tabs, between rooms, between intentions. I pick something up and put it down before it has time to matter.
It doesn’t feel like I can’t focus. It feels like nothing is asking me to.
That distinction matters more than I expected. Because the language I’ve been given for most of my life doesn’t account for it. Attention deficit. Hyperactivity. Disorder. Words that suggest a lack of capacity, a surplus of noise, a system that is fundamentally broken. For most people, interest is a boost. For me, it’s a threshold.
But from the inside, it feels less like deficit and more like variable activation.
In neuropsych terms, ADHD isn’t just about attention. It’s about dopaminergic regulation—how the brain assigns salience, how it decides what is worth engaging with. The issue isn’t that attention is absent. It’s that it’s context-dependent.
When something is novel, complex, emotionally charged, or intrinsically interesting, dopamine spikes. The system engages. Networks synchronize. The default mode network quiets, the task-positive network takes over, and suddenly focus isn’t effortful—it’s automatic.
When something lacks those features, the system doesn’t engage. Not because it can’t, but because, at a neurochemical level, it isn’t being tagged as important.
That’s the part that never made it into the diagnosis.
On medication, that gap is bridged artificially. Dopamine availability increases, norepinephrine sharpens signal-to-noise, and the brain becomes more willing to treat low-salience tasks as actionable. The threshold for engagement drops. You don’t need interest to begin.
Off medication, the threshold returns.
And with it, the selectivity.
For a long time, I interpreted that as failure. A lack of discipline. A personal inconsistency that needed to be corrected, ideally with chemistry.
Then I came across a study from the University of Bath that asked a different question.
Instead of asking what people with ADHD lack, it asked what they’re good at—creativity, humor, hyperfocus, cognitive flexibility. Traits that tend to get framed as compensations or side effects.
But the more interesting finding wasn’t the list of strengths. It was what actually predicted whether people were doing well.
It wasn’t just having strengths. It was strengths knowledge and strengths use—knowing what you’re good at and being able to deploy it in daily life. Across both ADHD and non-ADHD groups, greater strengths use was associated with better wellbeing, better quality of life, and fewer mental health symptoms.
Which is obvious, once you see it, and also clarifying in a way I wasn’t expecting.
Because it reframed the problem.
The issue wasn’t that I didn’t have strengths. It was that most of my days weren’t structured in a way that required them.
If your strengths are things like pattern recognition, associative thinking, emotional attunement, and the ability to sustain deep focus when something is engaging, then a day built around low-salience, low-novelty tasks isn’t just boring. It’s neurologically mismatched.
You don’t fail to show up for the day. The day fails to activate you.
Somewhere in the middle of thinking about all of this, I started using a different phrase.
Interest-driven attention.
It’s not clinical language, but it’s more accurate to the experience. Attention, in this model, is governed less by willpower and more by salience mapping—the brain’s ongoing calculation of what matters enough to engage.
Interest, in this sense, isn’t a preference. It’s a signal.
It reflects dopaminergic tagging, network alignment, the recruitment of cognitive resources. When something registers as interesting, it isn’t just subjectively appealing—it is, at a systems level, actionable.
When something doesn’t, it isn’t just unappealing—it’s inert.
Medication flattens that distinction. It allows attention to be applied more evenly across tasks, regardless of their intrinsic salience. That’s useful. It’s often necessary.
But it also obscures the underlying pattern: that attention, left to its own devices, is selective for a reason.
If you live in a world built around obligation-based attention, this creates friction. Most institutions—education, work, bureaucracy—are optimized for consistency, not variability. They assume that attention should be stable, deployable, and largely independent of context.
An interest-driven system doesn’t behave that way.
It oscillates. It spikes. It locks in under the right conditions and disengages under the wrong ones. From the outside, that looks like inconsistency. From the inside, it feels like misalignment between the system you have and the environment you’re in.
The study doesn’t solve that mismatch. It doesn’t redesign the structures that reward uniform attention. But it does shift the frame.
Instead of asking why I can’t focus, I’ve started asking what my attention is waiting for.
That question is more demanding. It implies that the problem isn’t just internal. It’s ecological. It has to do with how tasks are framed, how environments are structured, how meaning is generated or withheld.
I’ve started paying attention to when I feel “on.” Not in a vague sense, but in a measurable one. When time compresses. When effort drops. When I’m able to sustain attention without forcing it.
It happens in situations with high cognitive and emotional salience: teaching, where ideas are live and relational; writing, when concepts collide; conversations that have tension or stakes.
Those are not rare capacities. They’re context-specific activations.
The challenge isn’t to become someone who can focus on anything. It’s to build a life that contains more of the conditions that make focus possible.
I don’t think I’m done with medication. That would be a different kind of simplification. But I am less interested in the idea that my attention needs to be corrected, and more interested in understanding the system that’s already there.
“Attention deficit” suggests absence.
From where I’m sitting, it looks more like differential engagement.
Which is less a disorder than a distribution problem.
I’m still figuring out how to work with that.
But for now, it’s enough to say that I’m not trying to fix my attention anymore.
I’m trying to understand what it responds to—and build a life that responds back.



